Vasopressin and Oxytocin

Historical Overview: Vasopressin Receptors: A Historical Survey; S. Jard. Biosynthesis of Vasopressin and Oxytocin. Cell-Specific Gene Expression in Oxytocin and Vasopressin Magnocellular Neurons; H. Gainer. Hypothalamic Transcription Factors and the Regulation of the Hypothalamo-Neurohypophysial System; J.P.H. Burbach, et al. POU Domain Factors in Neural Development; M.D. Schonemann, et al. Local Protein Synthesis in Magnocellular Dendrites: Basic Elements and Their Response to Hyperosmotic Stimuli; Dan Ma, J.F. Morris. Vasopressin Gene Expression in Rat Choroid Plexus; A. Chodobski, et al. Neuronal Activity and Release. Electrophysiological Distinctions between Oxytocin and Vasopressin Neurons in the Supraoptic Nucleus; W.E. Armstrong, J.E. Stern. Mechanisms of Neuroendocrine Cell Excitability; G.I. Hatton, Zhenhui Li. Properties of the Transient K+ Current in Acutely Isolated Supraoptic Neurons from Adult Rat; T.E. Fisher, C.W. Bourque. Gaba b Receptors and Supraoptic Neuronal Activity; Q.J. Pittman, et al. Local Glutamatergic and Gabaergic Synaptic Circuits and Metabotropic Glutamate Receptors in the Hypothalamic Paraventricular and Supraoptic Nuclei; J.G. Tasker, et al. Progesterone Regulates Hypothalamic Oxytocin mRNA Levels through Gamma Aminobutyric Acid; A. Thomas, J.A. Amico. Differential Effects of the Neurosteroid Pregnenolone Sulphate on Oxytocin and Vasopressin Neurones in Vitro; J.B. Wakerley, C.M. Richardson. Regulation of Vasopressin Release by Ionotropic Glutamate Receptor Agonists; D.J. Morsette, et al. Role of N-Methy-D-Aspartate (NMDA) Receptors in Vasopressin and Oxytocin Responses to Emotional Stimuli; K. Yagi, et al. Electrophysiological Studies of Oxytocin Neurons in Organotypic Slice Cultures; P. Jourdain, et al. Inhibitory Actions of Nociceptin (Orphanin FQ) on Rat Supraoptic Nucleus Oxytocin and Vasopressin Neurones in Vitro; N. Doi, et al. New Aspects of Firing Pattern Autocontrol in Oxytocin and Vasopressin Neurones; F. Moos, et al. Intrahypothalamic Vasopressin Release: An Inhibitor of Systemic Vasopressin Secretion? M. Ludwig, G. Leng. Differential Central and Peripheral Release of Vasopressin and Oxytocin in Response to Swim Stress in Rats; M. Engelmann, et al. Pregnancy and Aging: Two Model Systems with Altered Release Patterns of Oxytocin and Vasopressin within the Hypothalamus; I. Neumann, et al. Effect of Age and Testosterone on the Vasopressin Response to Dehydration in F344BNF1 Male Rats; J. Catudioc-Vallero, et al. Evidence for Nitric Oxide (NO) Actions throughout the Forebrain Osmoresponsive Circuit; S.M. Luckman. Gaseous Neurotransmitter Modulation of Vasopressin and Oxytocin Release; M.L. Forsling, A. Grossman. Membrane Excitability in the Neurohypophysis; R.A. Wilke, et al. Effects. Vasopressin's Depolarizing Action on Neonatal Rat Spinal Lateral Horn Neurons May Involve Multiple Conductances; M. Kolaj, L.P. Renaud. Vasopressin Action in the Mammalian Cerebral Cortex; R. Diaz Brinton, et al. Oxytocin, Vasopressin, and the Neuroendocrine Basis of Pair Bond Formation; T.R. Insel, et al. Central Oxytocin Neurotransmission: Receptor Characterisation and Role in Modulating Limbic Circuits in the Peripartum Period; C.D. Ingram, et al. Targeted Reduction of Oxytocin Expression Provides Insights into Its Physiological Roles; W.S. Young III, et al. Phenotypic Expression of and Oxytocin Peptide Null Mutation in Mice; J.T. Winslow, et al. Antiproliferative Effect of Oxytocin through Specific Oxytocin Receptors in Human Neuroblastoma and Astrocytoma Cell Lines; P. Cassoni, et al. Phosphorylation of Proteins Induced in a Murine Pre-T Cell Line by Neurohypophysial Peptides; H. Martens, et al. Signalling. Molecular Pharmacology of Human Vasopressin Receptors; M. Thibonnier, et al. Molecular Mechanisms Regulating the Effects of Oxytocin on Myometrial Intracellular Calcium; B.M. Sanborn, et al. Receptors: Expression and Regulation. Genomic and Non-Genomic Mechanisms of Oxytocin Receptor Regulation; H.H. Zingg, et al. The Molecular Basis of Oxytocin and Oxytocin Receptor Gene Expression in Reproductive Tissues; R. Ivell, et al. Transcriptional Regulation of the Oxytocin Receptor Gene; T.L. Bale, D.M. Dorsa. Female Reproduction in Mice Lacking the Prostaglandin F Receptor: Roles of Prostaglandin and Oxytocin Receptors in Parturition; Y. Sugimoto, et al. Expression of the Oxytocin Receptor and Oxytocin Gene in Human Oocytes and Preimplantation Embryos; S. Stock, C. Osterlund. Vasopressin Regulates Adrenal Functions by Acting through Different Vasopressin Receptor Subtypes; E. Grazzini, et al. All Three Vasopressin Receptor Sub-Types Are Expressed by Small-Cell Carcinoma; W.G. North, et al. Receptors: Structure/Function. Processing and Ligand-Induced Modifications of the V2 Vasopressin Receptor; H.M. Sadeghi, et al. Molecular Aspects of Vasopressin Receptor Function; T. Schoneberg, et al. Mapping Peptide Antagonist Binding Sites of the Human V1a and V2 Vasopressin Receptors; B. Mouillac, et al. Structure/Function Studies on Receptors for Vasopressin and Oxytocin; M. Wheatley, et al. Identification of a Constitutively Active Mutant of the Human Oxytocin Receptor; B. Chini, et al. Identification of Neurohypophysial Hormone Receptor Domains Involved in Ligand Binding and G. Protein Coupling; R. Postina, et al. Mutations in the Vasopressin V2 Receptor and Aquaporin-2 Genes in Twelve Families with Congenital Nephrogenic Diabetes Insipidus; R. Vargas-Poussou, et al. Functional Study of Two V2 Vasopressin Mutant Receptors Related to NDI: P322S and P322H; D. Morin, et al. Renal Actions of Vasopressin. Studies of Renal Aquaporin-2 Expression during Renal Escape from Vasopressin-Induced Antidiuresis; J.G. Verbalis, et al. Prompt and Sustained Regulation of Aquaporin-2 by Arginine Vasopressin in Collecting Duct Cells and Clinical Implication of Urinary Excretion of Aquaporin-2; San-e Ishikawa, et al. Recent Advances in the Understanding of Water Metabolism in Heart Failure; R.W. Schrier, P.Y. Martin. Antagonists. Nonpeptide Antagonists for Vasopressin Receptors: Pharmacology of SR 121463A, A New Potent and Highly Selective V2 Receptor Antagonist; C. Serradeil-Le Gal. VPA-985, a Nonpeptide Orally Active and Selective Vasopressin V2 Receptor Antagonist; P.S. Chan, et al. Effects of Chronic AVP V2R Blockade in Congestive Heart Failure in Sheep: Comparison with Chronic ACE Inhibition; M. Naitoh, et al. Vasopressin Induces Opposite Changes in Blood Flow in the Skin and the Muscular Circulation; D. Hayoz, et al. Discovery of Novel Selective Hypotensive Vasopressin Peptides: A New Vasodilating Vasopressin Receptor? W.Y. Chan, et al. Safety, Tolerability, and Pharmacokinetics of SR 49059, a V1a Vasopressin Receptor Antagonist, after Repeated Oral Administration in Healthy Volunteers; R. Brouard, et al. Evidence for an Involvement of Vasopressin in Mechanism of Primary Dysmenorrhea and Effect of the Non-Peptide Vasopressin V1a Receptor Antagonist, SR 49059, on the Uterus of Non-Pregnant Women; M. Akerlund, et al. Progress in the Development of Oxytocin Antagonists for Use in Preterm Labor; P.D. Williams, et al. Index.